Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$17.09 USD
+0.21 (1.24%)
Updated May 14, 2024 04:00 PM ET
After-Market: $17.08 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Brokerage Reports
Teva Pharmaceutical Industries Ltd. [TEVA]
Reports for Purchase
Showing records 421 - 440 ( 455 total )
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Slew of new product launches likely to drive overall strong performance in CY12
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Slew of new product launches likely to drive overall strong performance in CY12..
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Near-term outlook remains bleak due to lack of FTF launches & delay in launch of an ‘undisclosed product’...
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Moderately revising downwards our CY11 estimates in view of dismal Q2CY11 performance
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Short term outlook remains bleak in view of ongoing manufacturing issues
Provider: FIRST GLOBAL
Analyst: THOMAS K